V P Werth Selected Research

Discoid Lupus Erythematosus

1/2022	Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study.
1/2018	Computerized planimetry to assess clinical responsiveness in a phase II randomized trial of topical R333 for discoid lupus erythematosus.
5/2012	The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V P Werth Research Topics

Disease

6	Cutaneous Lupus Erythematosus 01/2019 - 10/2000
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 10/2000
4	Pemphigus (Pemphigus Vulgaris) 10/2021 - 02/2000
3	Discoid Lupus Erythematosus 01/2022 - 05/2012
3	Dermatomyositis (Dermatopolymyositis) 01/2020 - 10/2015
2	Autoimmune Diseases (Autoimmune Disease) 10/2021 - 01/2020
2	Disease Progression 01/2020 - 02/2000
2	Atrophy 01/2008 - 07/2000
2	Rheumatoid Arthritis 08/2000 - 02/2000
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2019
1	Skin Diseases (Skin Disease) 01/2018
1	Pruritus (Itching) 01/2018
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Infections 07/2017
1	Neoplasms (Cancer) 07/2017
1	Inflammation (Inflammations) 06/2015
1	Necrosis 01/2008
1	Infarction (Infarctions) 01/2008
1	Dermatitis 01/2008
1	Oral Ulcer (Mouth Ulcer) 01/2004
1	Alopecia (Baldness) 01/2004
1	Injection Site Reaction 07/2001
1	Communicable Diseases (Infectious Diseases) 10/2000
1	Erythema elevatum diutinum 08/2000
1	Vasculitis (Vasculitides) 08/2000
1	Lupus Nephritis 07/2000
1	Multiple Sclerosis 07/2000
1	Osteosarcoma (Osteogenic Sarcoma) 07/2000
1	Systemic Scleroderma (Systemic Sclerosis) 02/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 11/2017 - 08/2000
2	AutoantibodiesIBA 10/2021 - 11/2019
2	Prostaglandins AIBA 07/2016 - 10/2015
2	Prednisone (Sone)FDA LinkGeneric 03/2015 - 07/2000
2	Etanercept (Enbrel)FDA Link 07/2001 - 08/2000
2	GlucocorticoidsIBA 07/2000 - 02/2000
1	dimemorfan (AT 17)IBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	DesmogleinsIBA 10/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2021
1	baricitinibIBA 01/2019
1	InterleukinsIBA 01/2018
1	R333IBA 01/2018
1	Syk KinaseIBA 01/2018
1	Janus KinasesIBA 01/2018
1	VaccinesIBA 07/2017
1	ChemokinesIBA 06/2015
1	CytokinesIBA 06/2015
1	Interleukin-10 (Interleukin 10)IBA 06/2015
1	Interleukin-12 (IL 12)IBA 06/2015
1	Interleukin-6 (Interleukin 6)IBA 06/2015
1	Interleukin-1 (Interleukin 1)IBA 06/2015
1	Interleukin-18 (Interleukin 18)IBA 06/2015
1	Interleukin-17 (Interleukin 17)IBA 06/2015
1	Infliximab (Remicade)FDA Link 03/2015
1	AntibodiesIBA 01/2015
1	Interferon Type IIBA 05/2012
1	InterferonsIBA 05/2012
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2008
1	MucinsIBA 01/2008
1	SS-B antibodiesIBA 01/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2000
1	Pharmaceutical PreparationsIBA 08/2000
1	Hyaluronan SynthasesIBA 07/2000
1	GlycosaminoglycansIBA 07/2000
1	Hyaluronic Acid (Hyaluronan)IBA 07/2000
1	Methylprednisolone FDA LinkGeneric 07/2000
1	RNA (Ribonucleic Acid)IBA 07/2000
1	Messenger RNA (mRNA)IBA 07/2000
1	Therapeutic UsesIBA 07/2000
1	Azathioprine (Imuran)FDA LinkGeneric 02/2000
1	Penicillamine (Cuprimine)FDA Link 02/2000

Therapy/Procedure

3	Therapeutics 01/2020 - 02/2000
1	Radiotherapy 07/2017
1	Biological Therapy 02/2017
1	Plasmapheresis 02/2000